Lumobiotics

Biopharma startup developing anti-cancer & anti-microbial photocontrollable peptidomimetics. 2-in-1 oncolytics + immunotherapy.

[Tim Schober @tim_schober]

„Towards in vivo photomediated delivery of anticancer peptides“
Major contribution from Ukrainian Scientists @professor_ik214 @KyivUniversity @EnamineLtd and UNCI, together with @lumobiotics @KITKarlsruhe
Thank you guys, you rock!
#StandWithUkraine
https://t.co/K2hwiIdguR

[Angewandte Chemie @angew_chem]

Diarylethene-based photoswitchable inhibitors of serine proteases (Ulrich) @KITKarlsruhe @lumobiotics #openaccess thanks to #projektDEAL https://t.co/35hYlsTTeg

[ACS Publications Bio & Med Chem Content @ACSBioMed]

SAR studies of diarylethene modified photoswitchable cytolytic peptides for anticancer and antimicrobial photopharmacology: maximizing the phototherapeutic indices. https://t.co/mjCZ0LNRKb

[Tim Schober @tim_schober]

Just published #openaccess in @ChemPhotoChem. Our efforts to control the uptake of cell-penetrating peptides by light. @grk2039 #H2020 #PELICO https://t.co/NkINHuLDqq

[Lumobiotics @lumobiotics]

Capital efficiency is key. Smarter, leaner trial design from preclinical to Ph4. Pharmacoeconomic analysis from early on. Goal-driven R&D. RWE will probably help a lot. AI/automation throughout.

[Frank S. David @Frank_S_David]

New data on increasing pharma competition: "market-leading" Rx today maintains that position for only 5.1 years, compared with 10.5 years in 2000.

Via @stuarthenderson & @AccentureLifSci colleagues: https://t.co/HreM8vvSah

[Lumobiotics @lumobiotics]

@UCSFMedicine @UCSF this is some top-level link-hacking u fell victim to! Look at this https://t.co/KBeXmRH44D

[Anirban Maitra @Aiims1742]

If you wanted a quick summary slide on the genomic landscape of #PancreaticCancer this is a good one to use. Cc: @precisionpanc
https://t.co/iW2hB19bs8

[sahil seth @[email protected] @sethsa]

Our paper on pre-existing functional heterogeneity in pancreatic cancer is out today!

We used early passage PDX models, with a high-resolution clonal tracing library to evaluate growth dynamics in-vitro and in-vivo.

A viale, A Carugo, A Li, I Ho @DraettaG, @Aiims1742 1/n

[Bruce Booth @LifeSciVC]

Sharing our "Year In Review": Annual Talk On Macro, Biotech, and Atlas.

A data-rich, whirlwind tour thru a bunch of pharma and biotech topics over about 45 min. Cheat sheet with timestamps included.

https://t.co/dh6Ln55prZ

[EIT Health @EITHealth]

Introducing to: Lumobiotics, a German biotech/pharma startup developing a safer & more efficient targeted therapy against solid tumors & localized antimicrobial-resistant infections @lumobiotics #biotech #EuropeanHealthCatapult

[BioRN Life Science Cluster Rhine-Neckar @BioRNCluster]

@lumobiotics, the catapult finalist from @KITKarlsruhe with its photoswitchable drugs against Tumors and for treatment of antimicrobial resistant infections. #EITHSummit #EHC

[Lumobiotics @lumobiotics]

@CDRLifeSciences @lumobiotics

[MEDiSTRAVA, an Inizio Company @MEDiSTRAVA_]

German biotech Lumobiotics fundraising to bring their therapy targeting pancreatic #cancer to the clinic #StartupSlam #BIOEUROPE

[Lumobiotics @lumobiotics]

Danke @BioRNCluster für die wunderbare Unterstützung die Sie uns geben @KITKarlsruhe #BioRN2017 #startup #Karlsruhe #biotech #Biotechnology https://t.co/Oshn7jhSUk

[BioRN Life Science Cluster Rhine-Neckar @BioRNCluster]

After reaching the finals of the #europeanhealth_catapult we're happy to welcome @lumobiotics again #BioRN2017 #startup

[Lumobiotics @lumobiotics]

@BioRNCluster @EITHealth We thank @BioRNCluster , @EITHealth for fantastic organisation! Many thanks to alma mater @KITKarlsruhe 🏆

[BioRN Life Science Cluster Rhine-Neckar @BioRNCluster]

Congratulations to @lumobiotics ! Fantastic Team from Karlsruhe working on photoswitchable drugs. #EHC2017 Biotech Semifinal. @EITHealth

[Innovation in Health (fmr EIT Health Germany) @hihh_inno]

The @BioRNCluster is a hotspot for #cancer research - Lumobiotics is one of most promising #startups from @KITKarlsruhe